Skip to main content
Premium Trial:

Request an Annual Quote

Morphosys Licenses Antibodies to Proteomika for Use in Companion Dxs

Premium

German biotech firm Morphosys said this week its ABd Serotec division has licensed seven of its diagnostic HuCAL antibodies to Spanish biomarker company Proteomika for use in its Promonitor diagnostic.

Promonitor is designed to determine circulating levels of different drugs and the immune response they trigger in patients.

It plans to launch kits in the second quarter of this year containing the HuCAL antibodies that can help monitor certain biopharmaceutical therapies.

Currently, Proteomika offers tests that monitor patients treated with anti-TNF and anti-CD20 agents and is developing similar diagnostics for use with other biopharmaceutical families.

Terms of the license call for ABd Serotec to receive royalties for product sales.

Further financial details of the agreement were not disclosed.

In March 2008, Proteomika ordered a number of antibodies from Morphosys for biomarker research (GWDN 03/05/2008). At the time, the order made Proteomika among the largest customers for ABd Serotec's custom monoclonal services.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.